Tuesday, February 9, 2010, 11:25pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Chembio Diagnostics, Inc. (CEMI.OB)

 At 15:53 EST: 0.26 USD  Up 0.01 (4.00%)  
MORE ON CEMI.OB
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
CHEMBIO DIAGNOSTICS (OTC BB:CEMI.OB) Delayed quote dataEdit
Last Trade: 0.26 USD
Trade Time: 3:53PM EST
Change: Up 0.01 (4.00%)
Prev Close: 0.25
Open: 0.25
Bid: 0.25 x 5000
Ask: 0.27 x 5000
1y Target Est: 0.50
Day's Range: 0.25 - 0.26
52wk Range: 0.08 - 0.57
Volume: 17,768
Avg Vol (3m): 41,450
Market Cap: 16.11M
P/E (ttm): N/A
EPS (ttm): -0.01
Div & Yield: N/A (N/A%)
Chembio Diagnostics, Inc. (CEMI.OB)
1d  5d  3m  6m  1y  2y  5y 
 Add CEMI.OB to Portfolio   Download Data

HEADLINES
• Chembio Enters $900,000 Development Contract With Contractor to CDC for Point of Care Influenza Test
Marketwire (Thu, Dec 17)
• CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Thu, Dec 17)
• CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Wed, Dec 2)
• Chembio CEO Discusses Company's HIV Testing Products on FOX News and Sirius Satellite Radio
Marketwire (Tue, Dec 1)
• Chembio Diagnostics Donates 4,500 HIV Test Kits for World AIDS Day
Marketwire (Tue, Dec 1)
• CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 17)
• Chembio Diagnostics to Present at the FDA Blood Products Advisory Committee on November 17, 2009
Marketwire (Tue, Nov 17)
• CHEMBIO DIAGNOSTICS, INC. Financials
EDGAR Online Financials (Tue, Nov 10)
• CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Wed, Nov 4)
• Chembio Reports Third Quarter 2009 Results
Marketwire (Wed, Nov 4)
More Headlines for CEMI.OB...
ANALYST
EPS Est (next year) (Dec-08) : N/A
EPS Est (in 2 years) (Dec-09) : N/A
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and markets rapid diagnostic tests for the detection of HIV antibodies in whole blood, serum, and plasma samples.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices